Show Them the Money: ASBCA Finds Govt Claims Untimely When Contractor Provided Cost Impact Analyses
Client Alert | 1 min read | 06.05.13
In Raytheon Corp. (April 22, 2013), the most recent in a string of CDA statute of limitations cases barring untimely government claims (discussed here, here, here, and here), the ASBCA dismissed the government's CAS-based claims relating to 3 out of the 4 accounting practice changes at issue, reminding contractors of the importance of complying with the regulatory requirement to provide timely estimates of the impacts of accounting changes. The Board allowed one claim to proceed "where Raytheon only reported the fact of a change, not the implications of it or other data" from which the Government could have concluded it had a claim, but dismissed as untimely 3 claims because Raytheon had provided cost impact information more than 6 years prior to the final decision asserting a Government claim, noting that "[c]laim accrual does not depend on the degree of detail provided, whether the contractor revises the calculations later, or whether the contractor characterizes the impact as 'immaterial,'" but is pegged instead to when the contractor "notified the Government of a specific, adverse cost impact flowing from [the change]."
Contacts
Insights
Client Alert | 7 min read | 11.05.26
2026 State Attorney General Elections: What Businesses Should Expect
As of November 4, 2026, the state attorney general elections point to increased enforcement in 2027, particularly in consumer protection, antitrust, AI, health care, and data centers.[1] Businesses should prepare for more investigations under existing laws and proposals for new legislation or rules. Campaign commitments indicate priorities, but their timing and implementation remain uncertain.[2]
Client Alert | 3 min read | 11.05.26
Federal, State, and Local Regulators Sue Toast Over B2B Advertising and Subscriptions
Client Alert | 3 min read | 11.04.26
CMS Proposal Would Overhaul Eligibility Rules for ACA Exchanges
Client Alert | 7 min read | 11.04.26
FDA Issues Guidance on Prescription Drug Use-Related Software

